Royal Bank of Canada
TLSI icon

Royal Bank of Canada’s TriSalus Life Sciences TLSI Stock Holding History

Royal Bank of Canada’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,194
Closed -$8K – 7690
2025
Q4 		$8K Buy
1,194
+843
+240% +$4.72K ﹤0.01% 6542
2025
Q3 		$2K Sell
351
-602
-63% -$2.82K ﹤0.01% 6915
2025
Q2 		$4K Buy
+953
New +$5.11K ﹤0.01% 6701

Other funds holding TLSI

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Royal Bank of Canada's TLSI Position: Q1 2026 in Review

Royal Bank of Canada sold out of TriSalus Life Sciences (TLSI) in Q1 2026, closing a stake of 1,194 shares — an estimated $8K sold.

Royal Bank of Canada first reported a position in TLSI in Q2 2025 and held it in 3 quarters. The position peaked at $8K in Q4 2025. 84 funds tracked by Wall St. Rank hold TLSI as of Q1 2026.

  • Royal Bank of Canada reported no remaining TriSalus Life Sciences position as of Q1 2026 after selling out during the quarter.
  • Royal Bank of Canada sold 1,194 TriSalus Life Sciences shares in Q1 2026, an estimated $8K.
  • Royal Bank of Canada first reported a position in TriSalus Life Sciences in Q2 2025 and held it in 3 quarters.
  • Royal Bank of Canada's TriSalus Life Sciences position peaked at $8K in Q4 2025.
  • 84 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.